Search
Menu
QPC Lasers Inc. - QPC Lasers is LIDAR 4-24 LB

Patent Granted for Treating Rheumatoid Arthritis

Facebook X LinkedIn Email
A US patent has been awarded to MorphoSys AG of Martinsried, Germany, and the University of Melbourne in Australia for use of antibodies against granulocyte-macrophage colony-stimulating factor. In 2007, the university granted MorphoSys an exclusive license for the patent family. The US patent will be used to treat the inflammation of rheumatoid arthritis by administering an antibody to patients that is directed against granulocyte-macrophage colony-stimulating factor.Read full article

Related content from Photonics Media



    Articles


    Webinars


    Photonics Dictionary Terms
    Published: January 2009
    antibodiesgranulocyte-macrophage colony-stimulating factorMorphoSys AGPatent NewsSlices from the Breadboard

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.